Akero Alumni Reassemble for Avere Therapeutics Launch Following Exit

By Elaine Chen · STAT News · 2026-07-14

The former leadership of Akero Therapeutics is partnering with Fairmount to establish a new biotech venture named Avere Therapeutics. According to reporting from STAT News, this publicly traded entity will focus on developing a long-acting immunology treatment acquired from a Chi

The former leadership of Akero Therapeutics is partnering with Fairmount to establish a new biotech venture named Avere Therapeutics. According to reporting from STAT News, this publicly traded entity will focus on developing a long-acting immunology treatment acquired from a Chi